UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer

British journal of surgery, 2007-12, Vol.94 (12), p.1468-1476

2007

Volltextzugriff (PDF)

Impact on Human Health of Microorganisms Present in Fermented Dairy Products: An Overview

BioMed research international, 2015-01, Vol.2015 (2015), p.1-13

2015

Volltextzugriff (PDF)

Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-08, Vol.28 (8), p.e45-e51

2016

Volltextzugriff (PDF)

Clinical Significance of CD147 in Children with Inflammatory Bowel Disease

BioMed research international, 2020, Vol.2020 (2020), p.1-7

2020

Volltextzugriff (PDF)

Microarray-Based Detection and Clinical Evaluation for Helicobacter pylori Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients

BioMed research international, 2018-01, Vol.2018 (2018), p.1-12

2018

Volltextzugriff (PDF)

Asymptomatic Hyperamylasemia in Stevens-Johnson Syndrome Is Associated with Intestinal Barrier Dysfunction

BioMed research international, 2020, Vol.2020 (2020), p.1-6

2020

Volltextzugriff (PDF)

Cost Analysis of Endoscopic Submucosal Dissection for the Treatment of Colorectal Lesions in China

BioMed research international, 2019-01, Vol.2019 (2019), p.1-7

2019

Volltextzugriff (PDF)

Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach

BioMed research international, 2017-01, Vol.2017 (2017), p.1-15

2017

Volltextzugriff (PDF)

Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy

BioMed research international, 2018-01, Vol.2018 (2018), p.1-8

2018

Volltextzugriff (PDF)

Update in Pathogenesis and Prospective in Treatment of Necrotizing Enterocolitis

BioMed research international, 2014-01, Vol.2014 (2014), p.1-9

2014

Volltextzugriff (PDF)

The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence

BioMed research international, 2015-01, Vol.2015 (2015), p.1-8

2015

Volltextzugriff (PDF)

Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation

BioMed research international, 2017-01, Vol.2017 (2017), p.1-6

2017

Volltextzugriff (PDF)

Anti-Actin IgA Antibodies Identify Celiac Disease Patients with a Marsh 3 Intestinal Damage among Subjects with Moderate Anti-TG2 Levels

BioMed research international, 2013-01, Vol.2013 (2013), p.1-6

2013

Volltextzugriff (PDF)

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021

Journal of gastroenterology, 2023-04, Vol.58 (4), p.313-345

2023

Volltextzugriff (PDF)

Annual Change in Pulmonary Function and Clinical Phenotype in Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2012, Vol.185 (1), p.44-52

2012

Volltextzugriff (PDF)

Traffic Control of Bacteria-Derived Molecules: A New System of Host-Bacterial Crosstalk

International Journal of Cell Biology, 2013, Vol.2013 (2013), p.500-507

2013

Volltextzugriff (PDF)

Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (9), p.873-882

2017

Volltextzugriff (PDF)

Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease

Clinical gastroenterology and hepatology, 2018-04, Vol.16 (4), p.542-549.e1

2018

Volltextzugriff (PDF)

Cadherin

Nihon rinshō, 1999-12, Vol.57 Suppl, p.433

1999

Volltextzugriff (PDF)

Multicenter epidemiological survey of pneumatosis intestinalis in Japan

BMC gastroenterology, 2022-05, Vol.22 (1), p.272-272, Article 272

2022

Volltextzugriff (PDF)

Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

Journal of gastroenterology, 2024-04, Vol.59 (4), p.302-314

2024

Volltextzugriff (PDF)

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

The lancet. Gastroenterology & hepatology, 2022-07, Vol.7 (7), p.648-657

2022

Volltextzugriff (PDF)

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)

Journal of gastroenterology, 2022-03, Vol.57 (3), p.174-184

2022

Volltextzugriff (PDF)

Outcomes after Pylorus‐preserving Gastrectomy for Early Gastric Cancer: A Prospective Multicenter Trial

World journal of surgery, 2004-09, Vol.28 (9), p.857-861

2004

Volltextzugriff (PDF)

1 – 25 von 1.432

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(998)
Mit Volltextzugriff
(1.186)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer

Impact on Human Health of Microorganisms Present in Fermented Dairy Products: An Overview

Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)

Clinical Significance of CD147 in Children with Inflammatory Bowel Disease

Microarray-Based Detection and Clinical Evaluation for Helicobacter pylori Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients

Asymptomatic Hyperamylasemia in Stevens-Johnson Syndrome Is Associated with Intestinal Barrier Dysfunction

Cost Analysis of Endoscopic Submucosal Dissection for the Treatment of Colorectal Lesions in China

Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach

Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy

Update in Pathogenesis and Prospective in Treatment of Necrotizing Enterocolitis

The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence

Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation

Anti-Actin IgA Antibodies Identify Celiac Disease Patients with a Marsh 3 Intestinal Damage among Subjects with Moderate Anti-TG2 Levels

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021

Annual Change in Pulmonary Function and Clinical Phenotype in Chronic Obstructive Pulmonary Disease

Traffic Control of Bacteria-Derived Molecules: A New System of Host-Bacterial Crosstalk

Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial

Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a multicenter prospective cohort study

Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease

Cadherin

Multicenter epidemiological survey of pneumatosis intestinalis in Japan

Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)

Outcomes after Pylorus‐preserving Gastrectomy for Early Gastric Cancer: A Prospective Multicenter Trial

Suchergebnisse filtern